Neutropenic complications in the PANTHER phase III study of adjuvant tailored dose-dense chemotherapy in early breast cancer.
Acta Oncol
; 59(1): 75-81, 2020 Jan.
Article
in En
| MEDLINE
| ID: mdl-31583943
Full text:
1
Database:
MEDLINE
Main subject:
Breast Neoplasms
/
Antineoplastic Combined Chemotherapy Protocols
/
Neutropenia
Type of study:
Clinical_trials
Language:
En
Journal:
Acta Oncol
Year:
2020
Type:
Article
Affiliation country:
Sweden